ACAT · NP Life Sciences Health Industry Group Inc. · Holdings
$10.00
At close · Oct 24
Return incl. dividend (before tax)
Going-concern doubt
— flagged Apr 16, 2024
Substantial doubt about the company's ability to continue as a going concern.
“The circumstances give rise to substantial doubt to the Company's ability to continue as a going concern within one year after the date that the financial statements are issued, and in order to remain solvent that the Company is dependent upon its ability to generate sufficient revenues to operate profitably or raise additional capital through debt financing and/or through sales of common stock. These conditions raise substantial doubt about the Company's ability to continue as a going concern. These consolidated financial statements do not include any adjustments to reflect the possible future effect on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from the outcome of these uncertainties. Management believes that the actions presently being taken to obtain additional funding and implement its strategic plan provides an opportunity for the Company to continue as a going concern.”View the 10-K filed Apr 16, 2024
Market Cap
$42.96M
Shares
4.30M
Volume · Oct 24
250
Avg daily vol (1 sessions)
—
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Institutional ownership from SEC Form 13F filings. Investment managers with more than $100 million in U.S. equities must disclose their positions every quarter, within 45 days of quarter-end, so the holdings shown can lag the market by up to a quarter.
Use institutional holdings through the 13F API or MCP →
See every holder of ACAT: 13F, 13D and 13G, insiders and funds →
Some SEC filings for this period have not finished importing. Holder totals and changes may be incomplete; these filings remain queued for recovery.
No Holdings Data
No institutional holdings data is available for this listed security yet.